Clonidine

Sujin Lee Weinstein, PharmD, BCPP

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Attention deficit hyperactivity disorder (ADHD) in pediatric patients (> 6 years old), as monotherapy or adjunctive therapy with stimulants

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Post traumatic stress disorder, Tourette’s syndrome, insomnia, opioid withdrawal symptoms

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.